sepsi
host
condit
system
inappropri
inflammatori
respons
invas
microorgan
although
mani
advanc
develop
antibiot
explos
knowledg
inflammatori
respons
sepsi
still
caus
one
million
death
year
first
week
life
current
accept
inappropri
host
inflammatori
respons
inappropri
defenc
mechan
play
import
role
develop
sepsi
cytokin
play
vital
role
regul
host
immun
respons
alter
express
cytokin
proven
involv
develop
sepsi
sever
risk
factor
sepsi
develop
identifi
caus
basic
differ
suscept
individu
popul
remain
unclear
recent
year
sever
group
provid
accumul
evid
indic
genet
background
host
influenc
suscept
prognosi
sepsi
previou
studi
suggest
variat
gene
encod
cytokin
involv
modul
inflammatori
respons
respons
interindividu
differ
suscept
sepsi
recent
epidemiolog
studi
suggest
singl
nucleotid
polymorph
snp
gene
encod
inflammatori
cytokin
may
influenc
cours
outcom
sepsi
explor
host
genet
marker
prognost
valu
sepsi
might
help
manag
neonat
would
like
benefit
aggress
antibiot
treatment
put
challeng
involv
perspect
therefor
identif
newborn
high
risk
develop
sepsi
could
help
us
develop
effect
prevent
strategi
tumour
necrosi
factor
interleukin
il
proinflammatori
cytokin
report
play
import
role
inflammatori
respons
pathogenesi
sepsi
syndrom
studi
cytokin
synthesis
begin
inflammatori
cascad
given
differ
result
studi
report
increas
concentr
proinflammatori
cytokin
system
circul
septic
newborn
other
demonstr
similar
even
lower
level
infect
newborn
compar
healthi
newborn
discrep
result
among
differ
studi
could
explain
differ
outcom
sepsi
seen
neonat
therefor
variabl
clinic
evolut
neonat
sepsi
relat
individu
variabl
cytokin
product
intens
inflamm
may
due
variat
genet
background
patient
result
differ
publish
studi
address
associ
snp
develop
sepsi
adult
neonat
contradictori
one
studi
suggest
allel
associ
increas
suscept
septic
shock
mortal
septic
shock
adult
howev
associ
consist
observ
studi
hedberg
et
al
septic
patient
present
aaga
genotyp
mortal
rate
sepsi
three
time
greater
seen
among
present
gg
genotyp
moreov
metaanalysi
studi
confirm
increas
risk
sepsi
carrier
allel
g
snp
regard
gene
polymorph
previou
studi
indic
snp
may
associ
poor
prognosi
sepsi
howev
studi
find
associ
polymorph
develop
bronchopulmonari
dysplasia
bpd
preterm
infant
hand
genet
variat
within
regulatori
part
gene
may
affect
incid
outcom
sepsi
associ
genotyp
sepsi
preterm
infant
report
hard
et
al
report
higher
incid
gg
genotyp
infant
develop
septicaemia
similarli
ahren
et
al
report
gg
genotyp
frequent
infant
sepsi
compar
infant
without
infect
consequ
genet
variabl
regulatori
code
region
inflammatori
cytokin
gene
may
influenc
suscept
andor
outcom
sepsi
report
previou
studi
high
level
creactiv
protein
crp
associ
earli
onset
sepsi
eo
infect
neonat
live
saudi
arabia
babi
carri
aallel
associ
high
level
circul
crp
appear
crp
eo
infect
cytokin
gene
polymorph
may
provid
use
biomark
screen
patient
risk
well
identif
like
benefit
specif
therapeut
choic
therefor
primari
aim
current
studi
investig
snp
tc
gc
ga
gene
possibl
associ
suscept
eo
saudi
newborn
infant
second
aim
evalu
associ
snp
gene
promot
circulatori
level
correspond
cytokin
prospect
cohort
crosssect
studi
carri
six
month
march
august
neonat
intens
care
unit
nicu
king
abdel
aziz
specialist
hospit
kaash
taif
citi
kingdom
saudi
arabia
ksa
total
newborn
infant
age
day
includ
studi
patient
enrol
met
follow
inclus
criteria
particip
studi
week
gestat
admiss
nicu
kaash
least
hour
fever
measur
consecut
two
occas
least
six
hour
apart
symptom
sign
sepsi
describ
previous
subject
classifi
three
differ
group
accord
nasr
et
al
group
control
group
babi
symptom
sign
sepsi
neg
blood
cultur
control
babi
consecut
enrol
studi
admit
newborn
nurseri
unit
routin
check
within
first
two
day
birth
group
ii
suspect
group
neonat
includ
infant
sign
symptom
sepsi
chorioamnion
born
mother
intrapartum
temperatur
prolong
ruptur
membran
hour
import
note
blood
cultur
group
neg
infect
confirm
mean
posit
blood
cultur
infant
put
group
iii
earli
onset
sepsi
eo
group
babi
clinic
examin
stay
nicu
sepsi
confirm
blood
sampl
taken
within
hour
birth
babi
suspect
sepsi
infect
proven
posit
cultur
treat
clinician
neonatologist
doubl
antibiot
ampicilin
gentamicin
babi
becam
symptom
free
finish
cours
antibiot
full
blood
count
routin
taken
investig
treatment
provid
free
charg
newborn
weigh
low
birth
weight
assess
clinic
differenti
intrauterin
growth
restrict
low
birth
weight
use
dubowitiz
score
system
pharmacolog
treatment
start
blood
collect
filter
paper
schleicher
schuell
dna
amplif
quantif
cytokin
two
ml
venou
blood
collect
edta
tube
becton
dickinson
meylan
franc
bacteri
cultur
dna
extract
filter
paper
use
store
peripher
blood
disc
size
filter
paper
incub
overnight
ml
saponin
pb
wash
minut
ml
pb
disc
pellet
boil
water
minut
dna
collect
supernat
centrifug
g
minut
follow
locat
investig
studi
tc
gc
ga
gene
genotyp
perform
nucleas
allel
discrimin
assay
designdemand
appli
biosystem
foster
citi
ca
describ
previous
interleukin
level
estim
use
highsensit
sandwich
elisa
kit
cambridg
uk
accord
manufactur
instruct
briefli
monoclon
antibodi
specif
cytokin
coat
onto
well
microtitr
plate
provid
sampl
standard
known
concentr
appli
plate
incub
period
biotinyl
monoclon
antibodi
specif
ad
incub
one
hour
wash
enzym
streptavidinhrp
bind
biotinyl
antibodi
ad
incub
one
hour
room
temperatur
tmb
substrat
solut
ad
plate
incub
dark
minut
room
temperatur
reaction
stop
use
hcl
absorb
measur
nm
use
micropl
reader
biotech
ca
usa
cytokin
concentr
determin
refer
standard
curv
construct
distribut
cytokin
genotyp
allel
frequenc
cytokin
concentr
analys
use
spss
version
spss
inc
chicago
il
usa
use
fisher
exact
test
snp
test
determin
popul
investig
show
deviat
genotyp
frequenc
expect
hardyweinberg
equilibrium
hwe
proport
test
perform
separ
case
control
logist
regress
analys
perform
assess
associ
genotyp
independ
variabl
associ
quantifi
use
odd
ratio
confid
interv
ci
cross
defin
statist
signific
heterozygot
genotyp
use
refer
analys
frequent
genotyp
sepsisfre
control
use
softwar
perform
overal
comparison
allel
frequenc
use
test
differ
cytokin
concentr
differ
studi
group
analys
use
kruskalw
test
pvalu
correct
tie
logist
regress
analys
perform
assess
associ
cytokin
serum
level
individu
differ
cytokin
genotyp
linkag
disequilibrium
ld
analysi
perform
fstat
version
find
haplotyp
associ
within
studi
group
studi
receiv
ethic
clearanc
ethic
committe
colleg
medicin
taif
univers
ksa
inform
consent
obtain
neonat
parentsleg
guardian
particip
studi
provid
adequ
inform
object
benefit
project
newborn
sepsi
significantli
higher
serum
level
proinflammatori
cytokin
compar
suspect
sepsisfre
control
group
overal
p
valu
tabl
shown
tabl
neonat
eo
significantli
higher
serum
level
compar
suspect
group
p
valu
respect
genotyp
frequenc
candid
snp
among
studi
group
without
sepsi
shown
tabl
polymorph
analys
studi
found
hwe
data
shown
tabl
cc
genotyp
allel
associ
eo
compar
suspect
patient
unadjust
analysi
cc
genotyp
ci
p
valu
c
allel
ci
p
valu
tabl
gg
cc
genotyp
associ
eo
patient
compar
suspect
patient
gg
genotyp
ci
p
valu
cc
genotyp
ci
p
valu
tabl
patient
carri
g
allel
associ
eo
compar
suspect
patient
ci
p
valu
tabl
howev
signific
associ
found
eo
patient
carri
c
allel
compar
suspect
group
hand
patient
carri
gg
genotyp
g
allel
significantli
associ
eo
compar
suspect
group
gg
genotyp
ci
p
valu
g
allel
ci
p
valu
tabl
aa
genotyp
allel
associ
eo
compar
suspect
patient
unadjust
analysi
aa
genotyp
ci
p
valu
allel
ci
p
valu
tabl
addit
investig
cytokin
snp
ld
result
indic
cytokin
snp
ld
data
shown
due
small
sampl
size
limit
risk
lose
fals
neg
result
order
investig
cytokin
snp
affect
circulatori
level
correspond
cytokin
associ
snp
level
analys
shown
tabl
signific
associ
cc
genotyp
higher
concentr
circul
cytokin
compar
heterozygot
tc
genotyp
ci
p
valu
gg
genotyp
associ
higher
level
circul
cytokin
compar
individu
carri
heterozyg
gc
genotyp
ci
p
valu
tabl
individu
carri
aa
genotyp
significantli
associ
lower
level
circul
cytokin
compar
individu
carri
ga
ci
p
valu
tabl
signific
associ
individu
carri
aa
genotyp
higher
concentr
cytokin
ci
p
valu
tabl
lower
concentr
cytokin
associ
individu
carri
tt
genotyp
compar
carri
genotyp
ci
p
valu
tabl
proinflammatori
cytokin
play
import
role
immun
respons
pathogenesi
sepsi
organ
dysfunct
singl
nucleotid
polymorph
cytokin
gene
may
explain
least
extent
variabl
clinic
cours
observ
sepsi
infect
major
previou
studi
relat
snp
sepsi
perform
adult
howev
data
neonat
popul
sepsi
poor
development
differ
affect
inflamm
immun
respons
make
difficult
extrapol
data
adult
studi
newborn
popul
current
studi
focus
analys
snp
four
gene
tc
gc
ga
may
play
critic
role
associ
inflammatori
respons
sepsi
sever
order
identifi
possibl
predict
mechan
sepsi
risk
stratif
interleukin
thought
one
key
mediat
pathogenesi
sepsi
syndrom
data
present
studi
clearli
show
newborn
eo
significantli
higher
serum
level
compar
suspect
sepsisfre
group
find
support
previou
studi
demonstr
elev
level
plasma
septic
neonat
compar
healthi
infant
infant
clinic
suspect
confirm
sepsi
therefor
sever
studi
evalu
role
cytokin
earli
diagnosi
neonat
sepsi
addit
data
clearli
show
signific
associ
cc
genotyp
higher
concentr
circul
cytokin
compar
heterozygot
tc
genotyp
also
cc
genotyp
allel
associ
eo
compar
suspect
patient
previou
data
indic
snp
may
associ
poor
prognosi
sepsi
howev
studi
find
associ
polymorph
outcom
sepsi
kang
et
al
conclud
polymorph
associ
develop
bronchopulmonari
dysplasia
preterm
infant
discrep
may
explain
differ
definit
sepsi
sever
studi
snp
gener
characterist
enrol
subject
includ
ethnic
interleukin
play
import
role
develop
pathogenesi
outcom
sepsi
septic
shock
data
present
investig
clearli
demonstr
neonat
eo
show
highli
signific
serum
level
compar
suspect
sepsisfre
group
find
agreement
previou
studi
report
excess
elev
septic
neonat
compar
healthi
infant
infant
clinic
suspect
confirm
sepsi
mani
investig
demonstr
level
circul
correl
sever
sepsi
may
predict
outcom
interleukin
appear
ideal
detect
earlyonset
neonat
infect
high
degre
sensit
specif
sinc
earli
marker
appear
crp
may
use
monitor
patient
high
risk
develop
infect
genet
variat
within
regulatori
part
gene
may
affect
incid
outcom
sepsi
data
show
gg
genotyp
associ
eo
compar
suspect
patient
allel
associ
eo
howev
signific
associ
found
allel
eo
addit
gg
genotyp
associ
higher
level
circul
cytokin
compar
individu
carri
heterozyg
gc
genotyp
result
accord
previou
studi
suggest
individu
allel
significantli
lower
plasma
concentr
allel
associ
reduc
plasma
level
newborn
bennermo
et
al
reveal
allel
function
vivo
increas
inflammatori
respons
similar
result
found
studi
includ
caucasian
infant
show
risk
neonat
sepsi
associ
snp
gg
howev
contradictori
result
seen
reiman
et
al
baier
et
al
studi
includ
verylowbirthweight
vlbw
infant
differ
ethnic
show
allel
associ
increas
incid
sepsi
hand
studi
detect
associ
snp
neonat
sepsi
contradict
data
variou
studi
could
attribut
differ
studi
design
ethnic
genetogen
genetoenvironment
interact
studi
report
allel
associ
higher
level
circul
eo
consequ
gene
polymorph
c
could
predictor
risk
develop
andor
predictor
sever
sepsi
saudi
newborn
popul
tumor
necrosi
factor
recognis
primari
mediat
pathophysiolog
sepsi
septic
shock
review
data
current
studi
show
serum
level
significantli
higher
eo
group
compar
suspect
sepsisfre
control
group
result
accord
previou
studi
demonstr
elev
serum
level
day
neonat
sepsi
role
earli
diagnost
marker
neonat
sepsi
evalu
regard
snp
gene
promot
data
present
indic
patient
carrier
gg
genotyp
g
allel
significantli
associ
eo
patient
compar
suspect
group
furthermor
individu
carri
aa
genotyp
significantli
associ
lower
level
circul
cytokin
compar
individu
carri
ga
genotyp
result
parallel
find
previou
studi
demonstr
pattern
protect
confer
ga
genotyp
sepsi
mortal
acut
respiratori
distress
syndrom
ard
outcom
paediatr
popul
similarli
adult
popul
anoth
studi
found
associ
snp
allel
protect
ard
howev
sever
studi
report
associ
snp
ga
sepsi
outcom
adult
paediatr
popul
studi
show
associ
snp
ga
increas
risk
sepsi
discrep
result
among
differ
studi
could
explain
variat
studi
design
enrol
subject
ethnic
genetogen
genetoenvironment
interact
addit
azevedo
et
al
specul
g
g
snp
gene
promot
seem
work
opposit
direct
could
fact
reflect
differ
impact
depend
age
data
studi
clearli
show
high
serum
level
eo
patient
compar
suspect
sepsisfre
control
group
high
level
could
lead
sideeffect
tachycardia
myalgia
malais
leucopaenia
weak
interferon
enhanc
lpsinduc
mortal
increas
level
lpsinduc
circul
consequ
antibodi
protect
lp
escherichia
coliinduc
mortal
addit
shown
mediat
lethal
therefor
ifng
could
play
import
role
sepsi
develop
outcom
result
demonstr
aa
genotyp
allel
associ
eo
compar
suspect
patient
signific
associ
individu
carri
aa
genotyp
higher
concentr
individu
carri
tt
genotyp
associ
lower
concentr
compar
carri
genotyp
allel
previous
report
associ
infecti
diseas
recent
allel
shown
associ
suscept
sever
acut
respiratori
syndrom
sar
individu
aa
genotyp
increas
risk
develop
sar
respect
mechan
allel
influenc
suscept
sepsi
may
therefor
depend
role
regul
product
conclus
circul
elev
eo
patient
allel
associ
eo
saudi
infant
howev
due
small
sampl
size
studi
cytokin
snp
ld
therefor
result
need
confirm
largescal
multicentr
prospect
studi
support
data
ethnic
popul
hope
could
use
develop
earli
predictor
prognosi
sepsi
neonat
